The global market for Naloxone Hydrochloride for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Naloxone Hydrochloride for Injection is a medication used to rapidly reverse opioid overdose. It works by blocking the effects of opioids in the brain and can quickly restore normal breathing in someone who has stopped breathing or is experiencing shallow breathing due to an opioid overdose.

North American market for Naloxone Hydrochloride for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Naloxone Hydrochloride for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Naloxone Hydrochloride for Injection include AuroMedics Pharma, Narcan, Somerset Therapeutics, Flagship Biotech International, Livealth BioPharma, Shanxi PUDE Pharmaceutical, Chengdu Easton Bio Pharmaceuticals, HeBei Aoxing Group Pharmaceutical, Hunan Kangzhe Pharmaceutical, Beijing Sihuan Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Naloxone Hydrochloride for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxone Hydrochloride for Injection.

The Naloxone Hydrochloride for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Naloxone Hydrochloride for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Naloxone Hydrochloride for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Naloxone Hydrochloride for Injection Market Report

Report Metric	Details
Report Name	Naloxone Hydrochloride for Injection Market
Segment by Type	1ml/Unit 2ml/Unit 10ml/Unit
Segment by Application	Hospital Pharmacy Retail Pharmacy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AuroMedics Pharma, Narcan, Somerset Therapeutics, Flagship Biotech International, Livealth BioPharma, Shanxi PUDE Pharmaceutical, Chengdu Easton Bio Pharmaceuticals, HeBei Aoxing Group Pharmaceutical, Hunan Kangzhe Pharmaceutical, Beijing Sihuan Pharmaceutical, Hainan Bikai Pharmaceutical, Chengdu Tiantai Mountain Pharmaceutical, Shandong Xinhua Pharmaceutical, Xi'an Disai Biopharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naloxone Hydrochloride for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naloxone Hydrochloride for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Naloxone Hydrochloride for Injection Market report?

Ans: The main players in the Naloxone Hydrochloride for Injection Market are AuroMedics Pharma, Narcan, Somerset Therapeutics, Flagship Biotech International, Livealth BioPharma, Shanxi PUDE Pharmaceutical, Chengdu Easton Bio Pharmaceuticals, HeBei Aoxing Group Pharmaceutical, Hunan Kangzhe Pharmaceutical, Beijing Sihuan Pharmaceutical, Hainan Bikai Pharmaceutical, Chengdu Tiantai Mountain Pharmaceutical, Shandong Xinhua Pharmaceutical, Xi'an Disai Biopharmaceutical

What are the Application segmentation covered in the Naloxone Hydrochloride for Injection Market report?

Ans: The Applications covered in the Naloxone Hydrochloride for Injection Market report are Hospital Pharmacy, Retail Pharmacy, Others

What are the Type segmentation covered in the Naloxone Hydrochloride for Injection Market report?

Ans: The Types covered in the Naloxone Hydrochloride for Injection Market report are 1ml/Unit, 2ml/Unit, 10ml/Unit

1 Naloxone Hydrochloride for Injection Market Overview

1.1 Product Definition

1.2 Naloxone Hydrochloride for Injection by Type

1.2.1 Global Naloxone Hydrochloride for Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 1ml/Unit

1.2.3 2ml/Unit

1.2.4 10ml/Unit

1.3 Naloxone Hydrochloride for Injection by Application

1.3.1 Global Naloxone Hydrochloride for Injection Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Global Naloxone Hydrochloride for Injection Market Size Estimates and Forecasts

1.4.1 Global Naloxone Hydrochloride for Injection Revenue 2020-2031

1.4.2 Global Naloxone Hydrochloride for Injection Sales 2020-2031

1.4.3 Global Naloxone Hydrochloride for Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Naloxone Hydrochloride for Injection Market Competition by Manufacturers

2.1 Global Naloxone Hydrochloride for Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Naloxone Hydrochloride for Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Naloxone Hydrochloride for Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Naloxone Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Naloxone Hydrochloride for Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Naloxone Hydrochloride for Injection, Product Type & Application

2.7 Global Key Manufacturers of Naloxone Hydrochloride for Injection, Date of Enter into This Industry

2.8 Global Naloxone Hydrochloride for Injection Market Competitive Situation and Trends

2.8.1 Global Naloxone Hydrochloride for Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Naloxone Hydrochloride for Injection Players Market Share by Revenue

2.8.3 Global Naloxone Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Naloxone Hydrochloride for Injection Market Scenario by Region

3.1 Global Naloxone Hydrochloride for Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Naloxone Hydrochloride for Injection Sales by Region: 2020-2031

3.2.1 Global Naloxone Hydrochloride for Injection Sales by Region: 2020-2025

3.2.2 Global Naloxone Hydrochloride for Injection Sales by Region: 2026-2031

3.3 Global Naloxone Hydrochloride for Injection Revenue by Region: 2020-2031

3.3.1 Global Naloxone Hydrochloride for Injection Revenue by Region: 2020-2025

3.3.2 Global Naloxone Hydrochloride for Injection Revenue by Region: 2026-2031

3.4 North America Naloxone Hydrochloride for Injection Market Facts & Figures by Country

3.4.1 North America Naloxone Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Naloxone Hydrochloride for Injection Sales by Country (2020-2031)

3.4.3 North America Naloxone Hydrochloride for Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Naloxone Hydrochloride for Injection Market Facts & Figures by Country

3.5.1 Europe Naloxone Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Naloxone Hydrochloride for Injection Sales by Country (2020-2031)

3.5.3 Europe Naloxone Hydrochloride for Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Naloxone Hydrochloride for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Naloxone Hydrochloride for Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Naloxone Hydrochloride for Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Naloxone Hydrochloride for Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Naloxone Hydrochloride for Injection Market Facts & Figures by Country

3.7.1 Latin America Naloxone Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Naloxone Hydrochloride for Injection Sales by Country (2020-2031)

3.7.3 Latin America Naloxone Hydrochloride for Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Naloxone Hydrochloride for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Naloxone Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Naloxone Hydrochloride for Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Naloxone Hydrochloride for Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Naloxone Hydrochloride for Injection Sales by Type (2020-2031)

4.1.1 Global Naloxone Hydrochloride for Injection Sales by Type (2020-2025)

4.1.2 Global Naloxone Hydrochloride for Injection Sales by Type (2026-2031)

4.1.3 Global Naloxone Hydrochloride for Injection Sales Market Share by Type (2020-2031)

4.2 Global Naloxone Hydrochloride for Injection Revenue by Type (2020-2031)

4.2.1 Global Naloxone Hydrochloride for Injection Revenue by Type (2020-2025)

4.2.2 Global Naloxone Hydrochloride for Injection Revenue by Type (2026-2031)

4.2.3 Global Naloxone Hydrochloride for Injection Revenue Market Share by Type (2020-2031)

4.3 Global Naloxone Hydrochloride for Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Naloxone Hydrochloride for Injection Sales by Application (2020-2031)

5.1.1 Global Naloxone Hydrochloride for Injection Sales by Application (2020-2025)

5.1.2 Global Naloxone Hydrochloride for Injection Sales by Application (2026-2031)

5.1.3 Global Naloxone Hydrochloride for Injection Sales Market Share by Application (2020-2031)

5.2 Global Naloxone Hydrochloride for Injection Revenue by Application (2020-2031)

5.2.1 Global Naloxone Hydrochloride for Injection Revenue by Application (2020-2025)

5.2.2 Global Naloxone Hydrochloride for Injection Revenue by Application (2026-2031)

5.2.3 Global Naloxone Hydrochloride for Injection Revenue Market Share by Application (2020-2031)

5.3 Global Naloxone Hydrochloride for Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AuroMedics Pharma

6.1.1 AuroMedics Pharma Company Information

6.1.2 AuroMedics Pharma Description and Business Overview

6.1.3 AuroMedics Pharma Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AuroMedics Pharma Naloxone Hydrochloride for Injection Product Portfolio

6.1.5 AuroMedics Pharma Recent Developments/Updates

6.2 Narcan

6.2.1 Narcan Company Information

6.2.2 Narcan Description and Business Overview

6.2.3 Narcan Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Narcan Naloxone Hydrochloride for Injection Product Portfolio

6.2.5 Narcan Recent Developments/Updates

6.3 Somerset Therapeutics

6.3.1 Somerset Therapeutics Company Information

6.3.2 Somerset Therapeutics Description and Business Overview

6.3.3 Somerset Therapeutics Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Somerset Therapeutics Naloxone Hydrochloride for Injection Product Portfolio

6.3.5 Somerset Therapeutics Recent Developments/Updates

6.4 Flagship Biotech International

6.4.1 Flagship Biotech International Company Information

6.4.2 Flagship Biotech International Description and Business Overview

6.4.3 Flagship Biotech International Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Flagship Biotech International Naloxone Hydrochloride for Injection Product Portfolio

6.4.5 Flagship Biotech International Recent Developments/Updates

6.5 Livealth BioPharma

6.5.1 Livealth BioPharma Company Information

6.5.2 Livealth BioPharma Description and Business Overview

6.5.3 Livealth BioPharma Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Livealth BioPharma Naloxone Hydrochloride for Injection Product Portfolio

6.5.5 Livealth BioPharma Recent Developments/Updates

6.6 Shanxi PUDE Pharmaceutical

6.6.1 Shanxi PUDE Pharmaceutical Company Information

6.6.2 Shanxi PUDE Pharmaceutical Description and Business Overview

6.6.3 Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.6.5 Shanxi PUDE Pharmaceutical Recent Developments/Updates

6.7 Chengdu Easton Bio Pharmaceuticals

6.7.1 Chengdu Easton Bio Pharmaceuticals Company Information

6.7.2 Chengdu Easton Bio Pharmaceuticals Description and Business Overview

6.7.3 Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Product Portfolio

6.7.5 Chengdu Easton Bio Pharmaceuticals Recent Developments/Updates

6.8 HeBei Aoxing Group Pharmaceutical

6.8.1 HeBei Aoxing Group Pharmaceutical Company Information

6.8.2 HeBei Aoxing Group Pharmaceutical Description and Business Overview

6.8.3 HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.8.5 HeBei Aoxing Group Pharmaceutical Recent Developments/Updates

6.9 Hunan Kangzhe Pharmaceutical

6.9.1 Hunan Kangzhe Pharmaceutical Company Information

6.9.2 Hunan Kangzhe Pharmaceutical Description and Business Overview

6.9.3 Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.9.5 Hunan Kangzhe Pharmaceutical Recent Developments/Updates

6.10 Beijing Sihuan Pharmaceutical

6.10.1 Beijing Sihuan Pharmaceutical Company Information

6.10.2 Beijing Sihuan Pharmaceutical Description and Business Overview

6.10.3 Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.10.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates

6.11 Hainan Bikai Pharmaceutical

6.11.1 Hainan Bikai Pharmaceutical Company Information

6.11.2 Hainan Bikai Pharmaceutical Description and Business Overview

6.11.3 Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.11.5 Hainan Bikai Pharmaceutical Recent Developments/Updates

6.12 Chengdu Tiantai Mountain Pharmaceutical

6.12.1 Chengdu Tiantai Mountain Pharmaceutical Company Information

6.12.2 Chengdu Tiantai Mountain Pharmaceutical Description and Business Overview

6.12.3 Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.12.5 Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates

6.13 Shandong Xinhua Pharmaceutical

6.13.1 Shandong Xinhua Pharmaceutical Company Information

6.13.2 Shandong Xinhua Pharmaceutical Description and Business Overview

6.13.3 Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.13.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates

6.14 Xi'an Disai Biopharmaceutical

6.14.1 Xi'an Disai Biopharmaceutical Company Information

6.14.2 Xi'an Disai Biopharmaceutical Description and Business Overview

6.14.3 Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Product Portfolio

6.14.5 Xi'an Disai Biopharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Naloxone Hydrochloride for Injection Industry Chain Analysis

7.2 Naloxone Hydrochloride for Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Naloxone Hydrochloride for Injection Production Mode & Process Analysis

7.4 Naloxone Hydrochloride for Injection Sales and Marketing

7.4.1 Naloxone Hydrochloride for Injection Sales Channels

7.4.2 Naloxone Hydrochloride for Injection Distributors

7.5 Naloxone Hydrochloride for Injection Customer Analysis

8 Naloxone Hydrochloride for Injection Market Dynamics

8.1 Naloxone Hydrochloride for Injection Industry Trends

8.2 Naloxone Hydrochloride for Injection Market Drivers

8.3 Naloxone Hydrochloride for Injection Market Challenges

8.4 Naloxone Hydrochloride for Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AuroMedics Pharma

Narcan

Somerset Therapeutics

Flagship Biotech International

Livealth Biopharma

Shanxi Pude Pharmaceutical

Chengdu Easton Bio Pharmaceuticals

HeBei Aoxing Group Pharmaceutical

Beijing Sihuan Pharmaceutical

Hainan Bikai Pharmaceutical

Chengdu Tiantai Mountain Pharmaceutical

Shandong Xinhua Pharmaceutical

Xi'an Disai Biopharmaceutical

Hunan Kangzhe Pharmaceutical

List of Tables

Table 1. Global Naloxone Hydrochloride for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Naloxone Hydrochloride for Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Naloxone Hydrochloride for Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Naloxone Hydrochloride for Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Naloxone Hydrochloride for Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Naloxone Hydrochloride for Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Naloxone Hydrochloride for Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Naloxone Hydrochloride for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Naloxone Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Naloxone Hydrochloride for Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Naloxone Hydrochloride for Injection, Product Type & Application

Table 12. Global Key Manufacturers of Naloxone Hydrochloride for Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Naloxone Hydrochloride for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naloxone Hydrochloride for Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Naloxone Hydrochloride for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Naloxone Hydrochloride for Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Naloxone Hydrochloride for Injection Sales Market Share by Region (2020-2025)

Table 19. Global Naloxone Hydrochloride for Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Naloxone Hydrochloride for Injection Sales Market Share by Region (2026-2031)

Table 21. Global Naloxone Hydrochloride for Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Naloxone Hydrochloride for Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Naloxone Hydrochloride for Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Naloxone Hydrochloride for Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Naloxone Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Naloxone Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Naloxone Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Naloxone Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Naloxone Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Naloxone Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Naloxone Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Naloxone Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Naloxone Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Naloxone Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Naloxone Hydrochloride for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Naloxone Hydrochloride for Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Naloxone Hydrochloride for Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Naloxone Hydrochloride for Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Naloxone Hydrochloride for Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Naloxone Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Naloxone Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Naloxone Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Naloxone Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Naloxone Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Naloxone Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Naloxone Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Naloxone Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Naloxone Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Naloxone Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Naloxone Hydrochloride for Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Naloxone Hydrochloride for Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Naloxone Hydrochloride for Injection Sales Market Share by Type (2020-2025)

Table 53. Global Naloxone Hydrochloride for Injection Sales Market Share by Type (2026-2031)

Table 54. Global Naloxone Hydrochloride for Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Naloxone Hydrochloride for Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Naloxone Hydrochloride for Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Naloxone Hydrochloride for Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Naloxone Hydrochloride for Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Naloxone Hydrochloride for Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Naloxone Hydrochloride for Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Naloxone Hydrochloride for Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Naloxone Hydrochloride for Injection Sales Market Share by Application (2020-2025)

Table 63. Global Naloxone Hydrochloride for Injection Sales Market Share by Application (2026-2031)

Table 64. Global Naloxone Hydrochloride for Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Naloxone Hydrochloride for Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Naloxone Hydrochloride for Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Naloxone Hydrochloride for Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Naloxone Hydrochloride for Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Naloxone Hydrochloride for Injection Price (US$/Unit) by Application (2026-2031)

Table 70. AuroMedics Pharma Company Information

Table 71. AuroMedics Pharma Description and Business Overview

Table 72. AuroMedics Pharma Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. AuroMedics Pharma Naloxone Hydrochloride for Injection Product

Table 74. AuroMedics Pharma Recent Developments/Updates

Table 75. Narcan Company Information

Table 76. Narcan Description and Business Overview

Table 77. Narcan Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Narcan Naloxone Hydrochloride for Injection Product

Table 79. Narcan Recent Developments/Updates

Table 80. Somerset Therapeutics Company Information

Table 81. Somerset Therapeutics Description and Business Overview

Table 82. Somerset Therapeutics Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Somerset Therapeutics Naloxone Hydrochloride for Injection Product

Table 84. Somerset Therapeutics Recent Developments/Updates

Table 85. Flagship Biotech International Company Information

Table 86. Flagship Biotech International Description and Business Overview

Table 87. Flagship Biotech International Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Flagship Biotech International Naloxone Hydrochloride for Injection Product

Table 89. Flagship Biotech International Recent Developments/Updates

Table 90. Livealth BioPharma Company Information

Table 91. Livealth BioPharma Description and Business Overview

Table 92. Livealth BioPharma Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Livealth BioPharma Naloxone Hydrochloride for Injection Product

Table 94. Livealth BioPharma Recent Developments/Updates

Table 95. Shanxi PUDE Pharmaceutical Company Information

Table 96. Shanxi PUDE Pharmaceutical Description and Business Overview

Table 97. Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 99. Shanxi PUDE Pharmaceutical Recent Developments/Updates

Table 100. Chengdu Easton Bio Pharmaceuticals Company Information

Table 101. Chengdu Easton Bio Pharmaceuticals Description and Business Overview

Table 102. Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Product

Table 104. Chengdu Easton Bio Pharmaceuticals Recent Developments/Updates

Table 105. HeBei Aoxing Group Pharmaceutical Company Information

Table 106. HeBei Aoxing Group Pharmaceutical Description and Business Overview

Table 107. HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 109. HeBei Aoxing Group Pharmaceutical Recent Developments/Updates

Table 110. Hunan Kangzhe Pharmaceutical Company Information

Table 111. Hunan Kangzhe Pharmaceutical Description and Business Overview

Table 112. Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 114. Hunan Kangzhe Pharmaceutical Recent Developments/Updates

Table 115. Beijing Sihuan Pharmaceutical Company Information

Table 116. Beijing Sihuan Pharmaceutical Description and Business Overview

Table 117. Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 119. Beijing Sihuan Pharmaceutical Recent Developments/Updates

Table 120. Hainan Bikai Pharmaceutical Company Information

Table 121. Hainan Bikai Pharmaceutical Description and Business Overview

Table 122. Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 124. Hainan Bikai Pharmaceutical Recent Developments/Updates

Table 125. Chengdu Tiantai Mountain Pharmaceutical Company Information

Table 126. Chengdu Tiantai Mountain Pharmaceutical Description and Business Overview

Table 127. Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 129. Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates

Table 130. Shandong Xinhua Pharmaceutical Company Information

Table 131. Shandong Xinhua Pharmaceutical Description and Business Overview

Table 132. Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Product

Table 134. Shandong Xinhua Pharmaceutical Recent Developments/Updates

Table 135. Xi'an Disai Biopharmaceutical Company Information

Table 136. Xi'an Disai Biopharmaceutical Description and Business Overview

Table 137. Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Product

Table 139. Xi'an Disai Biopharmaceutical Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Naloxone Hydrochloride for Injection Distributors List

Table 143. Naloxone Hydrochloride for Injection Customers List

Table 144. Naloxone Hydrochloride for Injection Market Trends

Table 145. Naloxone Hydrochloride for Injection Market Drivers

Table 146. Naloxone Hydrochloride for Injection Market Challenges

Table 147. Naloxone Hydrochloride for Injection Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Naloxone Hydrochloride for Injection

Figure 2. Global Naloxone Hydrochloride for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Naloxone Hydrochloride for Injection Market Share by Type: 2024 & 2031

Figure 4. 1ml/Unit Product Picture

Figure 5. 2ml/Unit Product Picture

Figure 6. 10ml/Unit Product Picture

Figure 7. Global Naloxone Hydrochloride for Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Naloxone Hydrochloride for Injection Market Share by Application: 2024 & 2031

Figure 9. Hospital Pharmacy

Figure 10. Retail Pharmacy

Figure 11. Others

Figure 12. Global Naloxone Hydrochloride for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Naloxone Hydrochloride for Injection Market Size (2020-2031) & (US$ Million)

Figure 14. Global Naloxone Hydrochloride for Injection Sales (2020-2031) & (K Units)

Figure 15. Global Naloxone Hydrochloride for Injection Average Price (US$/Unit) & (2020-2031)

Figure 16. Naloxone Hydrochloride for Injection Report Years Considered

Figure 17. Naloxone Hydrochloride for Injection Sales Share by Manufacturers in 2024

Figure 18. Global Naloxone Hydrochloride for Injection Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Naloxone Hydrochloride for Injection Players: Market Share by Revenue in Naloxone Hydrochloride for Injection in 2024

Figure 20. Naloxone Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Naloxone Hydrochloride for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Naloxone Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 23. North America Naloxone Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 24. United States Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Naloxone Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 27. Europe Naloxone Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 28. Germany Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Naloxone Hydrochloride for Injection Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Naloxone Hydrochloride for Injection Revenue Market Share by Region (2020-2031)

Figure 35. China Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Naloxone Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 43. Latin America Naloxone Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Naloxone Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Naloxone Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Naloxone Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Naloxone Hydrochloride for Injection by Type (2020-2031)

Figure 53. Global Revenue Market Share of Naloxone Hydrochloride for Injection by Type (2020-2031)

Figure 54. Global Naloxone Hydrochloride for Injection Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Naloxone Hydrochloride for Injection by Application (2020-2031)

Figure 56. Global Revenue Market Share of Naloxone Hydrochloride for Injection by Application (2020-2031)

Figure 57. Global Naloxone Hydrochloride for Injection Price (US$/Unit) by Application (2020-2031)

Figure 58. Naloxone Hydrochloride for Injection Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions